A61K 49/1875
Coated or functionalised with an antibody
Official title: {coated or functionalised with an antibody}
A61K49/1875 (Coated or functionalised with an antibody) appears on 45 US grants and 97 published applications in this corpus.
Search patents in A61K- Granted patents
- 45
- Published applications
- 97
- Assignees
- 62
- Inventors
- 225
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 4 |
| 2003 | 2 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 2 |
| 2006 | 0 | 4 |
| 2007 | 0 | 5 |
| 2008 | 1 | 1 |
| 2009 | 0 | 7 |
| 2010 | 1 | 6 |
| 2011 | 1 | 6 |
| 2012 | 0 | 10 |
| 2013 | 0 | 5 |
| 2014 | 5 | 2 |
| 2015 | 2 | 7 |
| 2016 | 4 | 7 |
| 2017 | 1 | 2 |
| 2018 | 3 | 6 |
| 2019 | 3 | 3 |
| 2020 | 2 | 4 |
| 2021 | 2 | 4 |
| 2022 | 4 | 3 |
| 2023 | 1 | 6 |
| 2024 | 0 | 1 |
| 2025 | 2 | 0 |
| 2026 | 3 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Magnetic formulations for biomarker sampling and enhanced drug delivery22 Sep 2026US 12,741,038 B2Rocket Science Health Corp.
- Blood-brain barrier-penetrating nanotheranostics for acute and chronic neurodegenerative diseases and the like14 Jul 2026US 12,678,457 B2The Governing Council of the University of Toronto
- Conjugate and photoimmunotherapy2 Jun 2026US 12,642,863 B2Jsr Corporation
- Biocompatible magnetic materials8 Apr 2025US 12,268,756 B2MegaPro Biomedical Co., Ltd.
- Method for the site-specific covalent cross-linking of antibodies to surfaces8 Apr 2025US 12,270,809 B2The Trustees of the University of Pennsylvania
- Magnetic formulations for biomarker sampling and enhanced drug delivery5 Mar 2026US 2026/0061081 A1Rocket Science Health Corp.
- Method to assess nodal disease using iron oxide nanoparticles in magnetic resonance imaging8 Aug 2024US 2024/0261442 A1Imagion Biosystems, Inc.
- Blood-brain barrier-penetrating nanotheranostics for acute and chronic neurodegenerative diseases and the like19 Oct 2023US 2023/0330136 A1The Governing Council of the University of Toronto
- Conjugate and photoimmunotherapy19 Oct 2023US 2023/0330252 A1Jsr Corporation
- Magnetic resonance contrast agents and methods thereof3 Aug 2023US 2023/0241255 A1
Most cited
By later US patents
- Coated nanoparticles262US 6,548,264 B1University of Florida · 2003
- Resuspendable coated magnetic particles and stable magnetic particle suspensions146US 5,597,531 AImmunivest Corporation · 1997
- Process of making resuspendable coated magnetic particles81US 5,512,332 AImmunivest Corporation · 1996
- Diagnostic magnetometry using superparamagnetic particles76US 5,384,109 ANycomed Imaging AS · 1995
- Process and compounds for the magnetorelaxometric detection of analytes and use thereof36US 6,027,946 ASchering Corporation · 2000